Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the changes in B-type Natriuretic Peptide (BNP) and
amino-terminal fragment of proBNP (NT-proBNP) in outpatients managed in the heart failure
(HF) clinic initiated on the Angiotensin Receptor Neprilysin Inhibitor (Entresto) and
directly compare the prognostic values of BNP and NT-proBNP in patients admitted with acute
decompensated HF.
Phase:
N/A
Details
Lead Sponsor:
St. Michael's Hospital, Toronto Unity Health Toronto